Riggs Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,513
| Closed | -$220K | – | 658 |
|
|
2024
Q3 | $220K | Buy |
1,513
+1,406
| +1,314% | +$203K | 0.06% | 96 |
|
|
2024
Q2 | $14.7K | Sell |
107
-46,671
| -100% | -$6.23M | ﹤0.01% | 224 |
|
|
2024
Q1 | $6.42M | Buy |
+46,778
| New | +$6.39M | 1.87% | 17 |
|
|
2023
Q4 | – | Sell |
-169
| Closed | -$20.7K | – | 445 |
|
|
2023
Q3 | $20.7K | Hold |
169
| – | – | 0.01% | 188 |
|
|
2023
Q2 | $21.5K | Hold |
169
| – | – | 0.01% | 186 |
|
|
2023
Q1 | $21.8K | Buy |
169
+119
| +238% | +$15.6K | 0.01% | 176 |
|
|
2022
Q4 | $6.57K | Buy |
50
+30
| +150% | +$3.88K | ﹤0.01% | 232 |
|
|
2022
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 282 |
|
|
2022
Q2 | $2K | Buy |
+20
| New | +$2.37K | ﹤0.01% | 270 |
|
|
2022
Q1 | – | Sell |
-27
| Closed | -$4K | – | 327 |
|
|
2021
Q4 | $4K | Hold |
27
| – | – | ﹤0.01% | 279 |
|
|
2021
Q3 | $4K | Hold |
27
| – | – | ﹤0.01% | 273 |
|
|
2021
Q2 | $4K | Hold |
27
| – | – | ﹤0.01% | 271 |
|
|
2021
Q1 | $4K | Hold |
27
| – | – | ﹤0.01% | 243 |
|
|
2020
Q4 | $4K | Sell |
27
-53
| -66% | -$7.57K | ﹤0.01% | 230 |
|
|
2020
Q3 | $3K | Buy |
80
+11
| +16% | +$1.49K | ﹤0.01% | 154 |
|
|
2020
Q2 | $9K | Hold |
69
| – | – | ﹤0.01% | 176 |
|
|
2020
Q1 | $7K | Hold |
69
| – | – | ﹤0.01% | 188 |
|
|
2019
Q4 | $8K | Buy |
69
+42
| +156% | +$4.69K | ﹤0.01% | 216 |
|
|
2019
Q3 | $2K | Hold |
27
| – | – | ﹤0.01% | 218 |
|
|
2019
Q2 | $3K | Hold |
27
| – | – | ﹤0.01% | 228 |
|
|
2019
Q1 | $3K | Hold |
27
| – | – | ﹤0.01% | 215 |
|
|
2018
Q4 | $3K | Hold |
27
| – | – | ﹤0.01% | 201 |
|
|
2018
Q3 | $3K | Sell |
27
-27
| -50% | -$3.18K | ﹤0.01% | 208 |
|
|
2018
Q2 | $6K | Hold |
54
| – | – | ﹤0.01% | 196 |
|
|
2018
Q1 | $6K | Hold |
54
| – | – | ﹤0.01% | 217 |
|
|
2017
Q4 | $6K | Hold |
54
| – | – | ﹤0.01% | 212 |
|
|
2017
Q3 | $6K | Buy |
+54
| New | +$5.77K | ﹤0.01% | 209 |
|
|
2016
Q4 | – | Sell |
-150
| Closed | -$14K | – | 270 |
|
|
2016
Q3 | $14K | Hold |
150
| – | – | 0.01% | 180 |
|
|
2016
Q2 | $13K | Hold |
150
| – | – | 0.01% | 179 |
|
|
2016
Q1 | $13K | Hold |
150
| – | – | 0.01% | 171 |
|
|
2015
Q4 | $17K | Hold |
150
| – | – | 0.01% | 157 |
|
|
2015
Q3 | $15K | Hold |
150
| – | – | 0.01% | 165 |
|
|
2015
Q2 | $18K | Hold |
150
| – | – | 0.01% | 176 |
|
|
2015
Q1 | $17K | Hold |
150
| – | – | 0.01% | 173 |
|
|
2014
Q4 | $15K | Hold |
150
| – | – | 0.01% | 189 |
|
|
2014
Q3 | $14K | Buy |
+150
| New | +$13.2K | 0.01% | 181 |
|
Other funds holding IBB
Riggs Asset Management's IBB Position: Q4 2024 in Review
Riggs Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 1,513 shares — an estimated $220K sold.
Riggs Asset Management first reported a position in IBB in Q3 2014 and held it in 36 quarters. The position peaked at $6.42M in Q1 2024. 878 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- Riggs Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
- Riggs Asset Management sold 1,513 iShares Biotechnology ETF shares in Q4 2024, an estimated $220K.
- Riggs Asset Management first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 36 quarters.
- Riggs Asset Management's iShares Biotechnology ETF position peaked at $6.42M in Q1 2024.
- 878 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on Riggs Asset Management's 13F filing for Q4 2024, filed 24 Jan 2025.